ReviewCurrent urology reports2015
The role of MRI in active surveillance for prostate cancer.
Review in Current urology reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Article
- Opportunities for Achieving the Cancer Moonshot Goal of a 50% Reduction in Cancer Mortality by 2047.Cancer discovery · 2023Article
- Success of targeted transperineal biopsy in patients on surveillance for grade group 1 prostate cancer.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022Article
- Deep Learning Reconstruction Enables Highly Accelerated Biparametric MR Imaging of the Prostate.Journal of magnetic resonance imaging : JMRI · 2022Article
- The Reproducibility of Deep Learning-Based Segmentation of the Prostate Gland and Zones on T2-Weighted MR Images.Diagnostics (Basel, Switzerland) · 2021Article
- Assessment of magnetic resonance imaging (MRI)-fusion prostate biopsy with concurrent standard systematic ultrasound-guided biopsy among men requiring repeat biopsy.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2021Article
- Active surveillance for prostate cancer-will the discoveries of the last 5 years change the future?Translational andrology and urology · 2021Article
- Does a screening digital rectal exam provide actionable clinical utility in patients with an elevated PSA and positive MRI?BJUI compass · 2021Article
- Genitourinary cancer management during a severe pandemic: Utility of rapid communication tools and evidence-based guidelines.BJUI compass · 2020Review
- Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?BMC urology · 2019Article
- Natural history of prostatic lesions on serial multiparametric magnetic resonance imaging.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2018Article
- What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate.Radiology · 2018Article
- The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer.Abdominal radiology (New York) · 2017Article
- Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis.Abdominal radiology (New York) · 2017Article
- Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy.Urologic oncology · 2017Article
- Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers.Future oncology (London, England) · 2016Review
- How Active is Active Surveillance? Intensity of Followup during Active Surveillance for Prostate Cancer in the United States.The Journal of urology · 2016Article
- Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance?World journal of urology · 2016Article
- Editorial Comment.The Journal of urology · 2016Article
- Prostate Cancer Diagnosis on Repeat Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy of Benign Lesions: Recommendations for Repeat Sampling.The Journal of urology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Approximately one in seven American men will be diagnosed with prostate cancer during his lifetime, and at least 50% of newly diagnosed patients will present with low-risk disease. In the last decade, the decision-making paradigm for management has shifted due to high rates of disease detection and overtreatment, attributed to prostate-specific antigen screening, with more men deferring definitive treatment for active surveillance. The advent of multiparametric magnetic resonance imaging (MP-MRI) and MRI/ transrectal ultrasound-guided fusion-guided prostate biopsy has refined the process of diagnosis, identifying patients with clinically-significant cancer and larger disease burden who would most likely benefit from intervention. In parallel, the utilization of MP-MRI in the surveillance of low-grade, low-volume disease is on the rise, reflecting support in a growing body of literature. The aim of this review is to appraise and summarize the data evaluating the role of magnetic resonance imaging in active surveillance for prostate cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.